Abstract
Changes in technology, with decreases in the cost of molecular profiling, has expanded the interest in creating institution‐wide personalized medicine platforms to allow selective assessment of a given patient's tumor in real time, with the ability to utilize that information for patient‐care decisions. In order for this approach to function adequately, a multidisciplinary team must be created in an environment with dedicated support at an institutional level. J. Surg. Oncol. 2015 111:3–8.
Funding Information
  • National Cancer Institute (T32 CA009599)
  • Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy
  • Cancer Center Support Grant (CCSG P30 CA016672)
  • National Center for Research Resources grants (3UL1RR024148)

This publication has 28 references indexed in Scilit: